CN1033451C - α-取代的苯甲胺衍生物 - Google Patents

α-取代的苯甲胺衍生物 Download PDF

Info

Publication number
CN1033451C
CN1033451C CN92115152A CN92115152A CN1033451C CN 1033451 C CN1033451 C CN 1033451C CN 92115152 A CN92115152 A CN 92115152A CN 92115152 A CN92115152 A CN 92115152A CN 1033451 C CN1033451 C CN 1033451C
Authority
CN
China
Prior art keywords
formula
group
compound
hydrogen
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN92115152A
Other languages
English (en)
Chinese (zh)
Other versions
CN1073936A (zh
Inventor
M·A·C·扬森
G·H·P·范戴勒
J·-P·R·M·A·波斯曼斯
F·M·A·范登基巴斯
K·J·M·M·努扬斯
P·A·J·扬森
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of CN1073936A publication Critical patent/CN1073936A/zh
Application granted granted Critical
Publication of CN1033451C publication Critical patent/CN1033451C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/42—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/40—Nitrogen atoms attached in position 8
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/58—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems with hetero atoms directly attached to the ring nitrogen atom
    • C07D215/60—N-oxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/83—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CN92115152A 1991-12-30 1992-12-29 α-取代的苯甲胺衍生物 Expired - Fee Related CN1033451C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP91203430 1991-12-30
EP91203430.3 1991-12-30

Publications (2)

Publication Number Publication Date
CN1073936A CN1073936A (zh) 1993-07-07
CN1033451C true CN1033451C (zh) 1996-12-04

Family

ID=8208118

Family Applications (1)

Application Number Title Priority Date Filing Date
CN92115152A Expired - Fee Related CN1033451C (zh) 1991-12-30 1992-12-29 α-取代的苯甲胺衍生物

Country Status (17)

Country Link
US (2) US5407961A (OSRAM)
EP (1) EP0620809B1 (OSRAM)
JP (1) JPH07502524A (OSRAM)
CN (1) CN1033451C (OSRAM)
AP (1) AP406A (OSRAM)
AT (1) ATE149484T1 (OSRAM)
AU (1) AU664874B2 (OSRAM)
CA (1) CA2125676A1 (OSRAM)
DE (1) DE69217992T2 (OSRAM)
FI (1) FI943120A7 (OSRAM)
HU (1) HUT67030A (OSRAM)
IL (1) IL104258A (OSRAM)
MX (1) MX9207620A (OSRAM)
NO (1) NO942481D0 (OSRAM)
TW (1) TW249227B (OSRAM)
WO (1) WO1993013052A1 (OSRAM)
ZA (1) ZA9210079B (OSRAM)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE75693B1 (en) * 1990-07-10 1997-09-10 Janssen Pharmaceutica Nv HIV-inhibiting benzeneacetamide derivatives
US6001884A (en) * 1991-08-23 1999-12-14 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6313146B1 (en) 1991-08-23 2001-11-06 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6031003A (en) * 1991-08-23 2000-02-29 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5767310A (en) * 1993-03-19 1998-06-16 Merck & Co., Inc. Phenoxyphenylacetic acid derivatives
US5686478A (en) * 1993-07-20 1997-11-11 Merck & Co. Inc. Endothelin antagonists
US5538991A (en) * 1994-09-14 1996-07-23 Merck & Co., Inc. Endothelin antagonists bearing 5-membered heterocyclic amides
US5559135A (en) * 1994-09-14 1996-09-24 Merck & Co., Inc. Endothelin antagonists bearing pyridyl amides
HU228150B1 (en) 1994-10-21 2012-12-28 Nps Pharma Inc Calcium receptor-active compounds, medicaments comprising them, and the use of said medicaments
EP0907631B1 (en) * 1996-05-01 2003-06-18 Nps Pharmaceuticals, Inc. Inorganic ion receptor-active compounds
KR100686917B1 (ko) * 1998-06-19 2007-02-26 더 가번먼트 오브 더 유나이티드 스테이츠 오브 아메리카 레프리젠티드 바이 더 세크러터리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비시즈 새로운 티올에스테르 및 그것의 이용
CA2340241C (en) 1998-08-13 2011-10-04 Aventis Cropscience Gmbh Herbicidal compositions with acylated aminophenylsulfonylureas
US7067148B2 (en) 2001-02-15 2006-06-27 King Pharmaceutical Research & Development, Inc. Stabilized pharmaceutical and thyroid hormone compositions and method of preparation
US7101569B2 (en) 2001-08-14 2006-09-05 Franz G Andrew Methods of administering levothyroxine pharmaceutical compositions
WO2009105774A2 (en) 2008-02-21 2009-08-27 Sequoia Pharmaceuticals, Inc. Amino acid inhibitors of cytochrome p450

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4246429A (en) * 1978-06-23 1981-01-20 Janssen Pharmaceutica, N.V. Novel α-amino-phenylacetic acid derivatives
IT1226300B (it) * 1988-07-26 1990-12-27 Zambon Spa Processo per la preparazione di intermedi per la sintesi del diltiazem.
IE75693B1 (en) * 1990-07-10 1997-09-10 Janssen Pharmaceutica Nv HIV-inhibiting benzeneacetamide derivatives

Also Published As

Publication number Publication date
EP0620809B1 (en) 1997-03-05
AP406A (en) 1995-09-22
CA2125676A1 (en) 1993-07-08
MX9207620A (es) 1993-06-01
HU9401381D0 (en) 1994-08-29
TW249227B (OSRAM) 1995-06-11
IL104258A (en) 1997-04-15
WO1993013052A1 (en) 1993-07-08
DE69217992D1 (de) 1997-04-10
HUT67030A (en) 1995-01-30
FI943120L (fi) 1994-06-29
EP0620809A1 (en) 1994-10-26
US5407961A (en) 1995-04-18
US5480912A (en) 1996-01-02
JPH07502524A (ja) 1995-03-16
CN1073936A (zh) 1993-07-07
ATE149484T1 (de) 1997-03-15
DE69217992T2 (de) 1997-06-12
AP9200469A0 (en) 1993-01-31
NO942481L (OSRAM) 1994-06-30
ZA9210079B (en) 1994-06-29
FI943120A0 (fi) 1994-06-29
AU3258193A (en) 1993-07-28
IL104258A0 (en) 1993-05-13
FI943120A7 (fi) 1994-06-29
AU664874B2 (en) 1995-12-07
NO942481D0 (OSRAM) 1994-06-30

Similar Documents

Publication Publication Date Title
CN1033451C (zh) α-取代的苯甲胺衍生物
TWI272267B (en) Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
JP6063870B2 (ja) ＲＯＲγ活性の阻害用のＮ−スルホニル化テトラヒドロキノリンおよび関連二環化合物および病気の治療
JP2564462B2 (ja) 新規アリールアルキル（チオ）アミド化合物
CN1080260C (zh) 取代的吲哚衍生物以及它们作为iv型磷酸二酯酶(pde)和肿瘤坏死因子(tnf)抑制剂的用途
US7129270B2 (en) Nonsteroidal antiinflammatory agents
JP2891544B2 (ja) ピラゾロおよびピロロピリジン類
EP2766344B1 (en) Ep1 receptor ligands
JP6491679B2 (ja) Ｇａｂａａ受容体活性のモジュレーターとしてのイミダゾピリダジン誘導体
CN1136314A (zh) 用作消炎剂的异噁唑啉化合物
CZ2004634A3 (cs) Chinolinová sloučeninaŹ způsob výroby a použití a farmaceutický přípravek
CN1265649A (zh) 作为mcp－1受体拮抗剂的吲哚衍生物
CN1228775A (zh) 作为时间生物学药物的苯并呋喃和苯并吡喃
KR20090071632A (ko) 가축 동물에 대한 동화 제제로서 유용한 헤테로사이클릭 화합물
CN1771234A (zh) 吡咯并三嗪激酶抑制剂的制备方法
CN1064275A (zh) 咪唑并吡啶paf/h1拮抗剂
JPH09502170A (ja) フェネチルアミン化合物
JP2006117568A (ja) チオフェン環を有する新規アミド誘導体及びその医薬としての用途
EP2049493B1 (en) Compounds suitable as modulators of hdl
CN1034074C (zh) 杂环取代的苯甲胺衍生物的制备方法
JPH01156966A (ja) リポキシゲナーゼ抑制作用を有するピリダジノン、トリアジノンおよびオキサピリダジノン化合物
US7332485B2 (en) Peptide deformylase inhibitors
CN1395564A (zh) 作为mcp－1受体拮抗剂的吲哚类衍生物
JPH05246994A (ja) キノリルメトキシフエニル−アセトアミド類
JP2769058B2 (ja) シクロプロパン誘導体の製法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee